BioCentury
ARTICLE | Clinical News

Osta Biotechnologies preclinical data

July 12, 2010 7:00 AM UTC

In a mouse xenograft model of metastatic melanoma, IV OB-28 significantly reduced tumor volume compared with vehicle alone or IV dacarbazine, a generic alkylating agent. OB-28 is a small molecule hem...